Related Experiment Video
Updated: Jun 4, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics
Guang-Rong Yan1, Song-Hui Xu, Zi-Lu Tan
1Institute of Life and Health Engineering, and National Engineering and Research Center for Genetic Medicine, Jinan University, Guangzhou, P. R. China. tgryan@jnu.edu.cn
Abstract:
Although microRNAs (miRNAs) have been reported to play an important role in carcinogenesis, their molecular mechanism remains largely unknown because of our limited understanding of miRNA target genes. miR-373 was found to be capable of promoting breast cancer invasion and metastasis, but only a target gene was experimentally identified on the basis of mRNA expression analysis. In this study, we used SILAC-based quantitative proteomics to globally identify the genes regulated by miR-373. Totally, 3666 proteins were identified, and 335 proteins were found to be regulated by miR-373. Among the 192 proteins that were downregulated by miR-373, 27 (14.1%) were predicted to have at least one potential match site at their 3'-UTR for miR-373 seed sequence. However, miR-373 did not affect the mRNA level of the five selected candidate targets, TXNIP, TRPS1, RABEP1, GRHL2 and HIP1, suggesting that the protein expressions were regulated by miR-373 via translational inhibition instead of mRNA degradation. Luciferase and mutation assays validated that TXNIP and RABEP1 were the direct target genes of miR-373. More than 30 proteins reported to be involved in cancer invasion and metastasis were found to be regulated by miR-373 in breast cancer for the first time.
Insights
MicroRNAs (miRNAs) regulate protein expression. This study identified miR-373 targets in breast cancer, revealing its role in invasion and metastasis through translational inhibition, not mRNA degradation.
Area of Science:
- Molecular Biology
- Cancer Research
- Proteomics
Background:
- MicroRNAs (miRNAs) are implicated in cancer, but their target genes and mechanisms are poorly understood.
- miR-373 promotes breast cancer invasion and metastasis, yet few direct targets have been confirmed.
- Existing methods primarily focus on mRNA expression, limiting comprehensive target identification.
Purpose of the Study:
- To globally identify protein-coding genes regulated by miR-373 using quantitative proteomics.
- To elucidate the mechanism by which miR-373 influences protein expression in breast cancer.
- To validate direct targets of miR-373 involved in cancer progression.
Main Methods:
- Stable Isotope Labeling by Amino acids in Cell culture (SILAC)-based quantitative proteomics.
- Bioinformatic prediction of miRNA seed sequences in 3'-untranslated regions (3'-UTRs).
- Luciferase reporter assays and mutation analysis to confirm direct miRNA-target interactions.
Main Results:
- 3666 proteins were identified, with 335 found to be regulated by miR-373.
- Downregulation of 192 proteins by miR-373, with 27 predicted targets.
- TXNIP and RABEP1 validated as direct targets, regulated via translational inhibition.
- Over 30 proteins linked to cancer invasion and metastasis identified as miR-373 targets.
Conclusions:
- miR-373 regulates protein expression primarily through translational inhibition, not mRNA degradation.
- TXNIP and RABEP1 are direct targets of miR-373.
- This study reveals novel miR-373 targets involved in breast cancer invasion and metastasis, advancing understanding of miRNA regulatory networks in cancer.
More Related Videos
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017
09:52A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
Published on: January 10, 2025
Related Concept Videos
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
MicroRNAs
MicroRNAs